Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC-ESTRO OligoCare consortium.
Kroeze SGC, Pavic M, Stellamans K, Lievens Y, Becherini C, Scorsetti M, Alongi F, Ricardi U, Jereczek-Fossa BA, Westhoff P, But-Hadzic J, Widder J, Geets X, Bral S, Lambrecht M, Billiet C, Sirak I, Ramella S, Giovanni Battista I, Benavente S, Zapatero A, Romero F, Zilli T, Khanfir K, Hemmatazad H, de Bari B, Klass DN, Adnan S, Peulen H, Salinas Ramos J, Strijbos M, Popat S, Ost P, Guckenberger M. Kroeze SGC, et al. Among authors: billiet c. Lancet Oncol. 2023 Mar;24(3):e121-e132. doi: 10.1016/S1470-2045(22)00752-5. Lancet Oncol. 2023. PMID: 36858728 Review.
Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: a multicentre, randomised controlled open-label phase II trial.
Lieverse RIY, Van Limbergen EJ, Oberije CJG, Troost EGC, Hadrup SR, Dingemans AC, Hendriks LEL, Eckert F, Hiley C, Dooms C, Lievens Y, de Jong MC, Bussink J, Geets X, Valentini V, Elia G, Neri D, Billiet C, Abdollahi A, Pasquier D, Boisselier P, Yaromina A, De Ruysscher D, Dubois LJ, Lambin P. Lieverse RIY, et al. Among authors: billiet c. BMC Cancer. 2020 Jun 15;20(1):557. doi: 10.1186/s12885-020-07055-1. BMC Cancer. 2020. PMID: 32539805 Free PMC article.
Completeness of Reporting Oligometastatic Disease Characteristics in the Literature and Influence on Oligometastatic Disease Classification Using the ESTRO/EORTC Nomenclature.
Nevens D, Jongen A, Kindts I, Billiet C, Deseyne P, Joye I, Lievens Y, Guckenberger M. Nevens D, et al. Among authors: billiet c. Int J Radiat Oncol Biol Phys. 2022 Nov 15;114(4):587-595. doi: 10.1016/j.ijrobp.2022.06.067. Epub 2022 Jun 20. Int J Radiat Oncol Biol Phys. 2022. PMID: 35738308
Oncological outcome, postoperative complications, and mammographic changes after intraoperative radiotherapy with electrons (IOERT) as a boost in a large single-institution cohort of breast cancer patients.
Machiels M, Weytjens R, Erven K, Westerhoff JM, Amrouch S, Bosiers J, Verkinderen L, Hauspy J, van Dam P, Stevens P, Bernaerts A, Strijbos M, Meijnders P, Dirix P, Verellen D, Van Laere S, Vermeulen PB, Billiet C. Machiels M, et al. Among authors: billiet c. Breast J. 2020 Oct;26(10):1937-1945. doi: 10.1111/tbj.13986. Epub 2020 Aug 11. Breast J. 2020. PMID: 32779870
Optimal delineation of the clinical target volume for thymomas in the post-resection setting: A multi-center study.
Marcuse F, Peeters S, Herman K, Vaassen F, van Elmpt W, Maat APWM, Praag J, Billiet C, Van Schil P, Lambrecht M, Van Raemdonck D, Cao K, Grigoroiu M, Girard N, Hochstenbag M, Maessen J, De Ruysscher D. Marcuse F, et al. Among authors: billiet c. Radiother Oncol. 2021 Dec;165:8-13. doi: 10.1016/j.radonc.2021.10.007. Epub 2021 Oct 18. Radiother Oncol. 2021. PMID: 34673091 Free article.
39 results